Other Organic Chemical terms — page 4 | HESTIA Glossary

Browse all 9,913 other organic chemical terms HESTIA uses to describe agricultural data — with definitions and synonyms. Free and open.

(2-Methyl-3-phenylphenyl)methyl (1s,3s)-3-[(z)-2-chloro-3,3,3-trifluoroprop-1-enyl]-2,2-dimethylcyclopropane-1-carboxylate trans-3-(2-Chloro-3,3,3-trifluoro-1-propenyl)-2,2-dimethylcyclopropanecarboxylic acid (2-methyl[1,1'-biphenyl]-3-yl)methyl ester; Cyclopropanecarboxylic acid, 3-(2-chloro-3,3,3-trifluoro-1-propenyl)-2,2-dimethyl-, (2-methyl(; trans-Bifenthtin
(2-Naphthalenyl)hydrazine
(2-Naphthalenyloxy)acetic acid methyl ester Acetic acid, naphthyloxy-, methyl ester; 4-06-00-04274 (Beilstein Handbook Reference)
(2-Nitrophenoxy)acetic acid o-Nitrophenoxyacetic acid; (2-Nitrophenoxy)acetic acid; EINECS 217-527-9
(20R)-17,20-Dihydroxypregn-4-en-3-one sulphate
(20S)-17,20-Dihydroxypregn-4-en-3-one (20S)-17,20-dihydroxypregn-4-en-3-one; 652-69-7; 17alpha,20alpha-Dihydroxypregn-4-en-3-one; 4-Pregnen-17alpha,20alpha-diol-3-one; 17,20 alpha-OHP; C04518; 17 alpha, 20 alpha-P; 17 alpha, 20 alpha-OHP; SCHEMBL1191907; CHEBI:16418; DTXSID80331485; ZINC4096445; LMST02030183; 17a,20a-Dihydroxypregn-4-en-3-one; AKOS022181309; 17alpha,20alpha-Dihydroxypregna-4-ene-3-one; 17-alpha, 20-beta-dihydroxypreg-4-en-3-one; Q27101892; (8R,9S,10R,13S,14S,17R)-17-hydroxy-17-((S)-1-hydroxyethyl)-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one
(20Z,22Z)-28-Hydroxy-24-(1-hydroxyethyl)-10,16-dimethylspiro[2,5,13,18,25-pentaoxahexacyclo[22.3.1.114,17.01,3.07,12.07,16]nonacosa-10,20,22-triene-15,2'-oxirane]-4,19-dione 6,8a,11a,12,21,22-Hexahydro-23-hydroxy-19-(1-hydroxyethyl)-7,11a-dimethylspiro[10,12:19,22a-dimethano-4H,5H,22aH-oxireno[8,9][1,6,12]trioxacyclooctadecino[3,4-d][1]benzopyran-11(10H),2'-oxirane]-2,14(1aH,19H)-dione; Satratoxin G; BRN 4623147
(2E)-2-Methyl-3-phenyl-2-propenal ALPHA-METHYLCINNAMALDEHYDE; 101-39-3; a-Methylcinnamaldehyde; (E)-2-METHYL-3-PHENYLACRYLALDEHYDE; 15174-47-7; (E)-Alpha-Methylcinnamaldehyde; (E)-2-Methyl-3-phenylpropenal; 2-Methyl-3-phenylacrylaldehyde; 2-METHYL-3-PHENYLPROPENAL; UNII-1C647N9853; 2-Methyl-3-phenylacrolein; 2-Propenal, 2-methyl-3-phenyl-; NSC 22283; alpha-Methyl-trans-cinnamaldehyde; Cinnamaldehyde, .alpha.-methyl-; VLUMOWNVWOXZAU-VQHVLOKHSA-N; Cinnamaldehyde, alpha-methyl; alpha-Methylcinnimal; (2E)-2-methyl-3-phenylprop-2-enal; 2-methyl-3-phenylprop-2-enal; 1C647N9853; Cinnamaldehyde, alpha-methyl-; FEMA No. 2697; CCRIS 6257; EINECS 202-938-8; NSC-22283; NSC-49286; a-methyl cinnamaldehyde; BRN 0507514; .alpha.-Methylcinnimal; AI3-26230; .alpha.-Methylcinnamaldehyde; .alpha.-Methylcinnamic aldehyde; trans-Alpha-Methylcinnamaldehyde; (E)-2-Methyl-3-phenylacrolein; alpha-Methyl-trans-cinnamaldeyhde; alpha-Methylcinnamaldehyde [FHFI]; .alpha.-Methyl-trans-cinnamaldehyde; 2-Methyl-3-phenyl-2-propen-1-al; (E)-2-methyl-3-phenylprop-2-enal; 3-Phenylmethacrolein; trans-2-Methyl-3-phenyl-2-propenal; (2E)-2-Methyl-3-phenyl-2-propenal; 4-oxo-2-mercapto-thiazole-3-acetica acid; 3-phenyl-2-methylpropenal; EC 202-938-8; alpha-methyl-E-cinnamaldehyde; 2-07-00-00291 (Beilstein Handbook Reference); SCHEMBL186778; (E)-2-Methyl-3-phenyl-propenal; InChI=1/C10H10O/c1-9(8-11)7-10-5-3-2-4-6-10/h2-8H,1H3/b9-7; Cinnamic aldehyde, .alpha.-methyl; ALPHA-METHYL CINNAMYLALDEHYDE; BCP24559; ZINC4501386; BBL012658; MFCD00006976; SBB040229; STL163654; (E)-2-methyl-3-phenyl-prop-2-enal; 2-Methyl-3-phenyl-trans-prop-2-enal; AKOS000119680; AKOS025149199; alpha-Methyl-trans-cinnamaldehyde, 98%; NCGC00091690-02; AS-35370; H481; RT-001058; M0584; ST50213380; alpha-Methylcinnamaldehyde, >=97%, FCC, FG; W-108917; Q27252223; F2191-0168; 4549-82-0; alpha-Methylcinnamaldehyde; UNII-1C647N9853
(2E)-3,7-Dimethyl-2,6-octadien-1-ol 1-(N-methylcarbamate)
(2E)-3-(3-Methylphenyl)-2-propenoic acid
(2E)-3-Phenylprop-2-enoic acid Cinnamic acid; 4-09-00-02002 (Beilstein Handbook Reference)
(2E)-rel-3-[(2R,3R)-3-(6-Methoxy-2,6-dimethylheptyl)-2-oxiranyl]- 2-butenoic acid 1-methylethyl ester
(2E,4E)-11-Methoxy-3,7,11-trimethyldodeca-2,4-dienoic acid (2E,4E)-11-Methoxy-3,7,11-trimethyl-2,4-dodecadienoic acid; ZR-725; EINECS 258-355-4
(2E,4E)-2,4-Hexadienal 2,4-HEXADIENAL; Hexa-2,4-dienal; 142-83-6; Sorbaldehyde; Sorbic aldehyde; trans,trans-2,4-Hexadienal; (2E,4E)-hexa-2,4-dienal; 2,4-Hexadienal, (2E,4E)-; (2E,4E)-2,4-Hexadienal; (E,E)-2,4-hexadienal; 2,4-Hexadienal, (E,E)-; 2-Propyleneacrolein; 3-Propyleneacrolein; 80466-34-8; 1,3-Pentadiene-1-carboxaldehyde; Hexadienal; trans,trans-Hexa-2,4-dienal; UNII-878K4I6N7T; FEMA No. 3429; CCRIS 4030; CCRIS 5124; (E,E)-2,4-Hexadien-1-al; HSDB 7239; 2,4-Hexadien-1-al; EINECS 205-564-3; NSC 16184; NSC 68096; BRN 1698401; AI3-31142; 2,4-Hexadienal, trans,trans-; CHEBI:82334; trans,trans-2,4-Hexadien-1-al; BATOPAZDIZEVQF-MQQKCMAXSA-N; 878K4I6N7T; MFCD00007004; trans, trans-2,4-hexadienal; (2E,4E)-Hexadienal; 2,4-(e-e)-hexadienal; (E,E)-hexa-2,4-dienal; (E)-2,(E)-4-Hexadienal; InChI=1/C6H8O/c1-2-3-4-5-6-7/h2-6H,1H3/b3-2+,5-4; 73506-81-7; 2-Propylene acrolein; e,e-2,4-hexadienal; trans-2,4-hexadienal; t,t-2,4-Hexadienal; (2E,4E) hexadienal; trans,trans-4-Hexadienal; DSSTox_CID_5391; (2E)-2,4-Hexadienal; 2,4-(E,E)-Hexadienal; DSSTox_RID_77769; DSSTox_GSID_25391; (2e,4z)-2,4-hexadienal; 4-01-00-03545 (Beilstein Handbook Reference); Trans,trans-2,4-Hexadienal.; CHEMBL1576086; DTXSID2025391; Hexa-2,4-dienal, (E,E)-; (2E,4E/Z)-2,4-hexadienal; (2E,4E)-2,4-Hexadienal #; n-Hex-2,4-dienal, trans,trans-; 2,4-Hexadien-1-al, (E,E)-; trans,trans-2,4-Hexadienal, 95%; ZINC1733897; Tox21_200834; 6992AA; LMFA06000006; LS-840; AKOS015915466; trans,trans-2,4-Hexadienal, >=95%; NCGC00090786-01; NCGC00090786-02; NCGC00090786-03; NCGC00258388-01; CAS-142-83-6; LS-74880; DB-003137; RT-002647; ST2419409; TC-172853; C19249; trans,trans-2,4-Hexadienal, analytical standard; A807974; J-007704; Q27155883; 2,4-Hexadienal (89% trans,trans-, 11% cis,trans-); 2,4-HEXADIENAL (2,4-DECADIENAL (25152-84-5)); 20432-44-4; 2,4-Hexadienal; 4-01-00-03545 (Beilstein Handbook Reference)
(2E,4E)-5-(1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl)-3-methyl-2,4-pentadienoic acid
(2E,4E)-5-(4-Nitrophenyl)penta-2,4-dienal 5-(4-Nitrophenyl)-2,4-pentadienal; CCRIS 53; 2,4-Pentadienal, 5-(4-nitrophenyl)-; (2E,4E)-5-(4-nitrophenyl)penta-2,4-dienal; 5-(4-Nitrophenyl)-2,4-pentadienal; 2608-48-2; 5-(4-Nitrophenyl)-2,4-pentadien-1-al; CTK4F7040; CTK4J1526; AKOS030240697; 2,4-Pentadienal,5-(4-nitrophenyl)-; LS-1093; 5-(4-NITROPHENYL)-2,4-PENTADIEN-1-AL (NPPD); 49678-09-3; (2E,4E)-5-(4-Nitrophenyl)-2,4-pentadienal; (2E,4E)-5-(4-nitrophenyl)penta-2,4-dienal; 5-(4-Nitrophenyl)-2,4-pentadienal; 2608-48-2; Spy dust; 5-(4-Nitrophenyl)-2,4-pentadien-1-al; NPPD; EC-000.1744; SCHEMBL2559008; SCHEMBL2559010; DTXSID6025773; ZINC2036005; ZX-CM015202; AKOS006339852; LS-190716; LS-194395; W-6198; (2E,4E)-5-(4-Nitro-phenyl)-penta-2,4-dienal; CCRIS 53; 5-(4-Nitrophenyl)-2,4-pentadienal; 2,4-Pentadienal, 5-(4-nitrophenyl)-; 2608-48-2; ZINC31622667; CCRIS 53
(2E,4E)-5-[(1S)-1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl]-3-methyl-2,4-pentadienoic acid
(2E,4Z)-5-(1-Hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1-yl)-3-methylpenta-2,4-dienoic acid (E,Z)-5-(1-Hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl)-3-methyl-2,4-pentadienoic acid; 2,4-Pentadienoic acid, 5-(1-hydroxy-2,6,6-trimethyl-4-oxo-2-cyclohexen-1-yl)-3-methyl-, (E,Z)-; NA
(2E,5E)-2-[(2E)-3-(2,5-Dihydro-2-hydroxy-5-oxo-3-furanyl)-2-propenylidene]-6-methyl-8-(2,6,6-trimethyl-1-cyclohexen-1-yl)-5-octenal
(2R)-2-(2,4-Dichlorophenoxy)propanoic acid methyl ester
(2R)-2-(4-Chloro-2-methylphenoxy)propanoic acid 2-butoxyethyl ester
(2R)-2-Amino-4-(hydroxymethylphosphinyl)butanoic acid Glufosinate, (R)-; UNII-M758GI0FEX
(2R)-2-[(Dimethoxyphosphinyl)thio]butanedioic acid, 1,4-Diethyl ester
(2R)-2-[4-[4-(Aminocarbonyl)-2-fluorophenoxy]phenoxy]propanoic acid
(2R,3E,12bS)-2-[(4,9-Dihydro-3H-pyrido[3,4-b]indol-1-yl)methyl]-3-ethylidene-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizine
(2R,3R,4R)-2,3,4,5-Tetrahydroxypentanal D-Ribose; D-Rib; D-Ribopyranose; D-Ribopyranoside; D-Ribose; Rib; Ribopyranose; Ribopyranoside; Ribose; 10257-32-6; (3R,4R,5R)-tetrahydro-2H-pyran-2,3,4,5-tetrol; (3R,4R,5R)-Tetrahydro-2H-pyran-2,3,4,5-tetraol; EC 700-481-3; D-Ribose, 99.0%+; SCHEMBL339948; CHEBI:47006; CTK0H1736; DTXSID70450356; SRBFZHDQGSBBOR-SOOFDHNKSA-N; C21057; R-5495; Q27120754; Ribose; 4-01-00-04211 (Beilstein Handbook Reference)
(2R,3R,4S,5S,6S)-5-Amino-2-[[(2R,3S,4R,6S,7R)-7-amino-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxycyclohexyl]oxy-4-hydroxy-3-(methylamino)-2,3,4,4a,6,7,8,8a-octahydropyrano[3,2-b]pyran-2-yl]oxy]-6-(hydroxymethyl)oxane-3,4-diol Caseins, hydrolyzates; Casein hydrolysate; Acid digest of casein
(2R,3S,5R)-2-Bromo-1,1,9-trimethyl-5-methylenespiro[5.5]undec-8-en-3-ol
(2R,4R)-Difenoconazole 1-[[(2R,4R)-2-[2-Chloro-4-(4-chlorophenoxy)phenyl]-4-methyl-1,3-dioxolan-2-yl]methyl]-1H-1,2,4-triazole; Difenoconazole, (2R,4R)-; UNII-Q8DCQ746NH
(2R,4S)-4,5,10-Trihydroxy-8-methoxy-2-(2-oxopropyl)-3,4-dihydro-2H-benzo[g]chromene-6,9-dione (2R,4S)-3,4-Dihydro-4,5,10-trihydroxy-8-methoxy-2-(2-oxopropyl)-2H-naphtho[2,3-b]pyran-6,9-dione; 2H-Naphtho(2,3-b)pyran-6,9-dione, 2-acetonyl-3,4-dihydro-4,5,10-trihydroxy-8-methoxy-, (+)-; (+)-Erythrostominone
(2R-cis)-3-Acetoxy-5-(2-(dimethylamino)ethyl)-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one monohydrochloride (2R,3R)-3-(Acetyloxy)-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one hydrochloride (1:1); (2R-cis)-3-Acetoxy-5-(2-(dimethylamino)ethyl)-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one monohydrochloride; EINECS 255-802-5
(2R-trans)-3-(Acetyloxy)-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one monohydrochloride
(2R2-[(Dimethoxyphosphinothioyl)thio]butanedioic acid, 1,4-Diethyl ester
(2S)-2-(2,4-Dichlorophenoxy)propanoic acid methyl ester
(2S)-2-(Acetylamino)-4-(hydroxymethylphosphinyl)butanoic acid
(2S)-2-Hydroxybutanedioic acid (S)-Hydroxybutanedioic acid; S-2-Hydroxybutanedioic acid; Apple acid
(2S)-2-Methyl-1-nitrosopiperidine S(+)-2-METHYL-N-NITROSOPIPERIDINE; (2S)-2-methyl-1-nitrosopiperidine; S(+)-N-Nitroso-2-methylpiperidine; S(+)-N-Nitroso-alpha-pipecoline; Piperidine, 2-methyl-N-nitroso-, S(+)-; 36702-44-0; S(+)-N-Nitroso-2-methyl-piperidin [German]; S(+)-2-Methyl-N-nitrosopiperidine; S(+)-N-Nitroso-2-methyl-piperidin; DTXSID1020853; ZINC5751926; (2S)-2-methyl-1-nitroso-piperidine; LS-7509; ACM36702440; [2S,(+)]-2-Methyl-1-nitrosopiperidine; A824067; Piperidine, 2-methyl-N-nitroso-, S(+)-; S(+)-N-Nitroso-2-methyl-piperidin [German]
(2S)-2-[(Dimethoxyphosphinyl)thio]butanedioic acid, 1,4-Diethyl ester
(2S)-2-[4-(2,4-Dichlorophenoxy)phenoxy]propanoic acid
(2S)-2-[4-[(6-Chloro-2-quinoxalinyl)oxy]phenoxy]propanoic acid ethyl ester
(2S)-N,N-Diethyl-2-(1-naphthalenyloxy)propanamide
(2S,3R,12bS)-3-Ethenyl-1,2,3,4,6,7,12,12b-octahydro-2-[[(1S)-2,3,4,9-tetrahydro-2-methyl-1H-pyrido[3,4-b]indol-1-yl]methyl]indolo[2,3-a]quinolizine
(2S,3R,4S,5S,6R)-2-[(1R,2R,3S,4S,6R)-2,3-Dihydroxy-6-(hydroxymethyl)-4-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]cyclohexyl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Validamycin; Validamycin; VALIDAMYCIN A; 37248-47-8; Validacin; Valimon; jinggangmycin; UNII-313E9620QS; T-7545-A; CHEBI:29703; 313E9620QS; (1S-(1alpha,4alpha,5beta,6alpha))-1,5,6-trideoxy-4-O-beta-D-glucopyranosyl-5-(hydroxymethyl)-1-((4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl)amino)-D-chiro-inositol; 1L-(1,3,4/2,6)-2,3-Dihydroxy-6-hydroxymethyl-4-((1S,4R,5S,6S)-4,5,6-trihydroxy-3-hydroxymethylcyclohex-2-enylamino)cyclohexyl beta-D-glucopyranoside; D-1,5,6-Trideoxy-3-O-beta-D-glucopyranosyl-5-(hydroxymethyl)-1-((4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl)amino)-D-chiroinositol; HSDB 6745; jinganmycin A; (1S-(1a,4a,5B,6a))-1,5,6-Trideoxy-3-O-B-D-glucopyranosyl-5-(hydroxymethyl)-1-((4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl)amino)-d-chiro-inositol; 1L-(1,3,4/2,6)-2,3-Dihydroxy-6-hydromethyl-4-((1S,4R,5S,6S)-4,5,6-trihydroxy-3-hydroxymethylcyclohex-2-enylamino)cyclohexyl beta-D-glucopyranoside; (+)-validamycin A; Validamycin (technical); (1R,2R,3S,4S,6R)-2,3-dihydroxy-6-(hydroxymethyl)-4-{[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}cyclohexyl beta-D-glucopyranoside; SCHEMBL3121491; CHEMBL1923413; DTXSID4058073; D-chiro-Inositol, 1,5,6-trideoxy-3-O-beta-D-glucopyranosyl-5-(hydroxymethyl)-1-((4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl)amino)-, (1S-(1-alpha,4-alpha,5-beta,6-alpha))-; ZINC8437016; AKOS016012982; AG-F-30599; (2R,3R,4S,5S,6R)-2-[(1R,2R,3S,4S,6R)-2,3-dihydroxy-6-(hydroxymethyl)-4-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]cyclohexyl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol; AS-15281; O743; SC-81107; TR-015151; C12112; K-8237; 248V478; Validamycin A, PESTANAL(R), analytical standard; W-204201; D-chiro-Inositol, 1,5,6-trideoxy-3-O-|A-D-glucopyranosyl-; D-Chiro-inositol,1,5,6-trideoxy-3-O-beta-D-glucopyranosyl-; (2R,3R,4S,5S,6R)-2-((1R,2R,3S,4S,6R)-2,3-dihydroxy-6-(hydroxymethyl)-4-((1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-enylamino)cyclohexyloxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol; (2R,3R,4S,5S,6R)-2-[(1R,2R,3S,4S,6R)-2,3-dihydroxy-6-(hydroxymethyl)-4-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]cyclohexoxy]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol; 1,5,6-trideoxy-4-O-beta-D-glucopyranosyl-5-(hydroxymethyl)-1-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl]amino]-D-chiro-inositol; Validamycins; Solacol
(2S,3aS,5aS,6R,9aR,9bR,10R)-2-(3-Furanyl)hexahydro-6-hydroxy-6-(hydroxymethyl)-10-methyl-3aH,6H-5a,9b-propano-5H-furo[2,3-c][2]benzopyran-12-one
(2S,4R)-1-(Tert-Butoxycarbonyl)-4-hydroxypyrrolidine-2-carboxylic acid (2S,4R)-1-(1,1-Dimethylethyl)ester 4-hydroxy-1,2-pyrrolidinedicarboxylic acid; trans-1-(tert-Butoxycarbonyl)-4-hydroxy-L-proline; (2S,4R)-1-tert-Butyl 4-hydroxy-1,2-pyrrolidinecarboxylate
(2S,4R)-Difenoconazole 1-[[(2S,4R)-2-[2-Chloro-4-(4-chlorophenoxy)phenyl]-4-methyl-1,3-dioxolan-2-yl]methyl]-1H-1,2,4-triazole; Difenoconazole, (2S,4R)-; UNII-75D9W6Q0SI
(2S,4aR,5R,6E,10aS,14cS)-6-Ethylidene-4a,5,6,7,8,9,10,14c-octahydro-2-hydroxy-8-methyl-4H-5,10a-ethano-3-oxa-8,14b-diazabenzo[a]cyclonon[cd]azulene-1,15(2H)-dione
(2S,4aR,5R,6E,10aS,14cS)-6-Ethylidene-4a,5,6,7,8,9,10,14c-octahydro-2-methoxy-8-methyl-4H-5,10a-ethano-3-oxa-8,14b-diazabenzo[a]cyclonon[cd]azulene-1,15(2H)-dione
(2S,5R,6R)-3,3-Dimethyl-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid Penicillin; Penicillin; Cillin; Benzopenicillin; Galofak; Compocillin G; 61-33-6; (Phenylmethyl)penicillin; 3,3-Dimethyl-7-oxo-6-[(phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 7005-30-3; NSC131815; (Phenylmethyl)penicillinic acid; NSC-193396; 3,3-dimethyl-7-oxo-6-((phenylacetyl)amino)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; Penicilline G sodium salt; Oprea1_713794; Oprea1_861345; CHEMBL300052; SCHEMBL2109546; CTK2H5530; DTXSID20274362; NSC11964; NSC-11964; NSC193396; STL453455; AKOS030242685; MCULE-3899419884; NCI60_000703; SC-58301; LS-187243; WLN: T45 ANV ESTJ CMV1R& F F GVQ; 3,3-Dimethyl-6-(phenylacetylamino)-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid,3-dimethyl-7-oxo-6-(2-phenylacetamido)-; 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid,3-dimethyl-7-oxo-6-[(phenylacetyl)amino]- [2S-(2.alpha.,5.alpha.,6.beta.)]-; 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid, 3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-; penicillin g; Benzylpenicillin; Benzylpenicillinic acid; Free penicillin II; Pencillin G; Benzylpenicillin G; Benzyl penicillin; Free penicillin G; Dropcillin; Gelacillin; Liquacillin; Pharmacillin; Cilopen; Pradupen; BencilpeniciliSpecilline G; Benzylpenicillinum; Cilloral; Cosmopen; Ursopen; Free benzylpenicillin; 61-33-6; Benzylpenicilline; Phenylacetamidopenicillanic acid; 6-(2-Phenylacetamido)penicillanic acid; Benzopenicillin; Benzyl-6-aminopenicillinic acid; Benzylpenicillin potassium; Penicillinic acid, benzyl-; (5R,6R)-Benzylpenicillin; Penicillin, (phenylmethyl)-; Galofak; Penicillin-G potassium; Compocillin G; bensylpenicillin; benzyl benicillin; Bencilpenicilina [Spanish]; Benzylpenicilline [French]; Benzylpenicillinum [Latin]; Penicillinic acid, (phenylmethyl)-; UNII-Q42T66VG0C; Benzylpenicillin [INN:BAN]; Penicillin; PENICILLIN-2; CHEBI:18208; Sodium penicillin; HSDB 3166; EINECS 200-506-3; NSC 193396; BRN 0044740; Sodium benzylpenicillin; (Phenylmethyl)penicillin; Q42T66VG0C; (2S,5R,6R)-3,3-Dimethyl-7-oxo-6-(2-phenylacetamido)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; C16H18N2O4S; (Phenylmethyl)penicillinic acid; 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-((phenylacetyl)amino)- (2S-(2alpha,5alpha,6beta))-; (2S,5R,6R)-3,3-dimethyl-7-oxo-6-(phenylacetamido)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-((phenylacetyl)amino)-, (2S-(2alpha,5alpha,6beta))-; 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-(2-phenylacetamido)-; Cillora; PenicillinG; (2S,5R,6R)-3,3-Dimethyl-7-oxo-6-(2-phenylacetamido)-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid; 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6- (2-phenylacetamido)-; 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-[(phenylacetyl)amino]- [2S-(2alpha,5alpha,6beta)]-; PNN; SMR000538912; NSC-193396; Penicillin,(S); 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-(2-phenylacetamido)-; PENICILLIN-G; Spectrum_000933; Benzylpenicillin (INN); CHEMBL29; Prestwick0_001078; Prestwick1_001078; Prestwick2_001078; Prestwick3_001078; Spectrum2_000518; Spectrum3_000542; Spectrum4_000471; Spectrum5_001108; Epitope ID:114070; SCHEMBL3783; BSPBio_001096; BSPBio_002183; KBioGR_000942; KBioSS_001413; (2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 4-27-00-05861 (Beilstein Handbook Reference); MLS000766897; MLS001032123; MLS001173382; DivK1c_000316; SPBio_000475; SPBio_002998; BPBio1_001206; GTPL4796; DTXSID5046934; CTK2F3306; KBio1_000316; KBio2_001413; KBio2_003981; KBio2_006549; KBio3_001683; J01CE01; JGSARLDLIJGVTE-MBNYWOFBSA-N; NINDS_000316; HMS2875L09; (2S,6R)-3,3-Dimethyl-7-oxo-6-(2-phenylacetamido)-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acid; ZINC3871701; BDBM50022787; Phenylacetyl-6-aminopenicillanic acid; AKOS005203091; API0003779; DB01053; IDI1_000316; NCGC00159348-02; NCGC00159348-03; 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-[(phenylacetyl)amino]- (2S,5R,6R)-; 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid, 3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]- (2S,5R,6R)-; CC-24547; SBI-0051476.P003; (2S,5R,6R)-3,3-dimethyl-7-oxo-6-; Bicillin (*Benzathine Salt, Tetrahydrate*); LS-149836; FT-0631271; FT-0770573; C05551; D02336; (2-phenylacetamido)-4-thia-1-azabicyclo[3.2.0]; 061P336; C-20153; Q258450; W-109262; BRD-K55191674-236-03-7; BRD-K55191674-237-02-7; BRD-K55191674-237-12-6; Benzylpenicillin, Antibiotic for Culture Media Use Only; 2,2-dimethyl-6beta-(phenylacetamido)penam-3alpha-carboxylic acid; (+)-3,3-Dimethyl-7-oxo-6-phenylacetylamino-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acid(penicillin G); (2S,5R,6R)-3,3-dimethyl-7-oxo-6-(2-phenylacetamido)-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acid; (2S,5R,6R)-3,3-DIMETHYL-7-OXO-6-[(PHENYLACETYL)AMINO]-4-THIA-1-AZABICYCLO[3.2.0]HEPTANE-2-CARBOXYLIC ACID; (2S,5R,6R)-3,3-Dimethyl-7-oxo-6-phenylacetylamino-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acid; 3,3-Dimethyl-7-oxo-6-phenylacetylamino-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acid; 3,3-Dimethyl-7-oxo-6-phenylacetylamino-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acid anion (Penicillin G); 3,3-Dimethyl-7-oxo-6-phenylacetylamino-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acid(penicillin G); 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-(2-phenylacetamido)- (8CI); 4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-[(phenylacetyl)amino]-, (2S,5R,6R)-; Penicillin G potassium; 113-98-4; Penicillin G potassium salt; Potassium benzylpenicillin; Benzylpenicillin potassium; Benzylpenicillin potassium salt; Penicillin G K; Potassium penicillin G; benzylpenicilline potassique; Potassium benzylpenicillinate; Potassium salt of benzylpenicillin; Pfizerpen G; Notaral; Penicillin G (potassium); UNII-VL775ZTH4C; Pfizerpen; PENICILLIN-2; CHEBI:7963; Penicillin potassium G, crystalline; Penicillin; VL775ZTH4C; Pentids; Penicillin G potassium [USP]; MLS000069426; 6beta-phenylacetamidopenicillanic acid potassium salt; potassium (2S,5R,6R)-3,3-dimethyl-7-oxo-6-(2-phenylacetamido)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate; Cilloral potassium salt; Cosmopen potassium salt; Pentids '200'; SMR000059004; PENTIDS '250'; PENTIDS '400'; PENTIDS '800'; Penicillin G potassium (USP); Benzylpenicilline potassique [DCF]; EINECS 204-038-0; Novocillin vet.; NSC 131815; Penicillin G Potassium in Plastic Container; 61-33-6 (FREE ACID); penicilline; Pfizerpen (TN); AI3-50119; Penicilline G potassium; NSC-131815; Opera_ID_1649; potassium; (2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate; Epitope ID:140781; CHEMBL1223; DSSTox_CID_25106; DSSTox_RID_80673; DSSTox_GSID_45106; SCHEMBL34078; MLS001076462; SPECTRUM1500465; DTXSID7045106; HMS500P18; IYNDLOXRXUOGIU-LQDWTQKMSA-M; HMS1920F12; HMS2091N12; HMS2234C21; Benzylpenicillin potassium (JP17); 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6- (2-phenylacetamido)-, monopotassium salt; 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-((2-phenylacetyl)amino)- (2S,5R,6R)-, potassium salt (1:1); 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-((phenylacetyl)amino)- (2S,5R,6R)-, monopotassium salt; 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-((phenylacetyl)amino)-, monopotassium salt, (2S-(2alpha,5alpha,6beta))-; BCP14289; Monopotassium (2S,5R,6R)-3,3-dimethyl-7-oxo-6-(2-phenylacetamido)-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate; Potassium (2S-(2alpha,5alpha,6beta))-3,3-dimethyl-7-oxo-6-(phenylacetamido)-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate; Tox21_110044; CCG-39599; MFCD00036193; AKOS008145411; CS-3873; MCULE-7644229995; NCGC00014313-01; AC-14408; AS-75133; CAS-113-98-4; CC-33871; CPD000059004; E705; HY-17591; SAM002548944; AB1009476; Penicillin G potassium salt, ~1600 U/mg; FT-0603312; P1772; D01053; Penicillin G potassium salt, >=98.0% (HPLC); C-21186; W-108609; Q27089370; Penicillin G potassium salt, powder, mouse embryo tested; Z803129904; Penicillin G potassium salt, VETRANAL(TM), analytical standard; Penicillin G Potassium, Antibiotic for Culture Media Use Only; Benzylpenicillin potassium, European Pharmacopoeia (EP) Reference Standard; Penicillin G potassium salt, meets USP testing specifications, powder; Penicillin G potassium salt, powder, BioReagent, suitable for cell culture; Penicillin G potassium, United States Pharmacopeia (USP) Reference Standard; potassium 2,2-dimethyl-6beta-(phenylacetamido)penam-3alpha-carboxylate; 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid,3,3-dimethyl-7-oxo-6-[(phenylacetyl)amino]- (2S,5R,6R)-,monopotassium salt; Benzylpenicillin potassium salt; potassium [2S-(2|A,5|A,6|A)]-3,3-dimethyl-7-oxo-6-(phenylacetamido)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate; Penicillin G sodium; Penicillin G sodium salt; 69-57-8; Benzylpenicillin sodium; Crystapen; American penicillin; Pencillin G sodium; Sodium penicillin G; BENZYLPENICILLIN SODIUM SALT; Sodium benzylpenicillinate; Sodium penicillin II; Mycofarm; Novocillin; Penilaryn; Veticillin; Sodium penicillin; Kesso-Pen; Pen-A-Brasive; Sodium benzylpenicillin G; Monosodium benzylpenicillin; Benzylpenicillinic acid sodium salt; Sodium benzylpenicillin; Penicillin G, sodium; Sugracillin sodium salt; Penicillin G Sodium, Crystalline; Sodium benzylpenicyllinate; UNII-YS5LY7JF4N; Penicillin-G, monosodium salt; Sodium 6-(phenylacetamido)penicillanate; EINECS 200-710-2; OK 431; YS5LY7JF4N; Penicillin; NSC 402815; Penicillin G sodium [USP]; CHEBI:51765; Penicillin G sodium (USP); 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-((phenylacetyl)amino)-, (2S-(2alpha,5alpha,6beta))-, monosodium salt; Monosodium (2S,5R,6R)-3,3-dimethyl-7-oxo-6-(2-phenylacetamido)-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate; PenicillinGsodiumsalt; Penicillin G sodium salt, 98%; 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-(2-phenylacetamido)-, monosodium salt; Sodium (2S-(2alpha,5alpha,6beta))-3,3-dimethyl-7-oxo-6-(phenylacetamido)-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate; 61-33-6 (FREE ACID); Penicillin G Sodium [USAN]; NSC-402815; Penicillin G sodium (TN); CHEMBL1126; C16H17N2NaO4S; SCHEMBL34218; C16H17N2O4S.DTXSID6040581; KS-00000WAN; BIP0142; BENZYL PENICILLIN POTASSIUM; FCPVYOBCFFNJFS-LQDWTQKMSA-M; ZX-AFC000647; HMS1571G18; HMS2098G18; HMS3715G18; 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-((phenylacetyl)amino)-(2S,5R,6R)-, monosodium salt; HY-B1463; MFCD00069666; s4160; AKOS015961217; CCG-221078; CS-7971; LS-1587; CAS-69-57-8; NCGC00017015-01; Penicillin G sodium salt, ~1650 U/mg; AC-13436; E706; K162; SC-16403; Penicillin G sodium salt, 96.0-102.0%; FT-0603271; P1770; SW197252-3; D05408; P-1200; Q27122736; F0001-2583; Pencillin G sodium salt, Antibiotic for Culture Media Use Only; sodium 2,2-dimethyl-6beta-(phenylacetamido)penam-3alpha-carboxylate; Benzylpenicillin sodium, European Pharmacopoeia (EP) Reference Standard; Penicillin G sodium salt, powder, BioReagent, suitable for cell culture; Penicillin G sodium, United States Pharmacopeia (USP) Reference Standard; PENICILLIN G, SODIUM SALT (ALSO SEE: 1538-09-6 BENZATHINE PEN. G); sodium (2S,5R,6R)-3,3-dimethyl-7-oxo-6-(2-phenylacetamido)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate; Sodium (2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0] heptane-2-carboxylate; Pfizerpen; Capicillin; Eskacillin; HiperciliSugracillin; Cintrisul; Cristapen; Falapen; Hyasorb; Hylenta; Lemopen; Liquapen; Monopen; Penalev; Penisem; Scotcil; Tabilin; Cillin; Forpen; Pentid; Tu Cillin; C-Cillin; Paclin G; Qidpen G; Megacillin tablets; SK-Penicillin G; Van-Pen-G; Pentids; Potassium benzylpenicillin G; Penicillin G, potassium salt; Penicillin; Cilloral potassium salt; Cosmopen potassium salt; Pentids '200'; Benzylpenicillinic acid potassium salt; PENTIDS '250'; PENTIDS '400'; PENTIDS '800'; Potassium 6-(phenylacetamido)penicillanate; Benzylpenicilline potassique [DCF]; Novocillin vet; EINECS 204-038-0; NSC 131815; AI3-50119; Penicillin G Potassium in Plastic Container; potassium 3,3-dimethyl-7-oxo-6-[(phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate; SCHEMBL6054109; Benzylpenicillin, potassium salt; Penicillin G Potassium [USAN]; C16H17N2O4S.K; CHEMBL1434858; CTK5A4315; HMS3259A18; HMS3370F17; 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6- (2-phenylacetamido)-, monopotassium salt; 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-((phenylacetyl)amino)- (2S,5R,6R)-, monopotassium salt; 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-((phenylacetyl)amino)-, monopotassium salt, (2S-(2alpha,5alpha,6beta))-; 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]- (2S,5R,6R)-, potassium salt (1:1); Monopotassium (2S,5R,6R)-3,3-dimethyl-7-oxo-6-(2-phenylacetamido)-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate; Potassium (2S-(2alpha,5alpha,6beta))-3,3-dimethyl-7-oxo-6-(phenylacetamido)-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate; MCULE-3955575945; NC00583; NCGC00094752-01; NCGC00094752-02; CPD001491654; SAM002564229; LS-149845; 55878-83-6; potassium 3,3-dimethyl-7-oxo-6-(2-phenylacetamido)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate; Penicillin; Penicillin G Na salt; NSC-402815; Benzyl penicillin Na salt; component of Crystifor '400'; PC-B-45; NSC402815; WLN: T45 ANV ESTJ CMV1R& F1 F1 GVQ; 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid,3-dimethyl-7-oxo-6-(2-phenylacetamido)-, monosodium salt; 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid,3-dimethyl-7-oxo-6-[(phenylacetyl)amino]- [2S-(2.alpha.,5.alpha.,6.beta.)]-, monosodium salt; EINECS 215-794-6
(2S2-[(Dimethoxyphosphinothioyl)thio]butanedioic acid, 1,4-Diethyl ester